中国心血管杂志2024,Vol.29Issue(5) :481-485.DOI:10.3969/j.issn.1007-5410.2024.05.016

血小板衍生生长因子在心肌梗死后心肌纤维化中作用的研究进展

Research progress of platelet-derived growth factor in cardiac fibrosis after myocardial infarction

蔡慧 陈淑霞 谷剑 齐鹏
中国心血管杂志2024,Vol.29Issue(5) :481-485.DOI:10.3969/j.issn.1007-5410.2024.05.016

血小板衍生生长因子在心肌梗死后心肌纤维化中作用的研究进展

Research progress of platelet-derived growth factor in cardiac fibrosis after myocardial infarction

蔡慧 1陈淑霞 2谷剑 2齐鹏3
扫码查看

作者信息

  • 1. 075000 张家口,河北北方学院研究生院
  • 2. 075000 张家口,河北北方学院研究生院;050017 石家庄,河北医科大学研究生院;050051 石家庄,河北省人民医院心血管内科
  • 3. 050051 石家庄,河北省人民医院心血管内科
  • 折叠

摘要

血小板衍生生长因子(PDGF)是机体纤维化过程的重要调节因子,在心脏中广泛表达.随着对PDGF的研究,我们对其在心肌纤维化机制中作用的认识更清晰.PDGF通过其活性形式与其受体结合,介导下游信号转导,在心肌纤维化的炎症、成纤维细胞增殖和血管生成阶段发挥重要作用.目前,已有多种PDGF受体相关靶向药物在动物实验中显示出可改善心肌纤维化,但其疗效仍需通过大量临床试验来验证.

Abstract

Platelet-derived growth factor(PDGF)is an important regulatory factor in fibrosis process and is widely expressed in the heart.Continued research on PDGF has led to a clearer understanding of its role in the mechanisms of myocardial fibrosis.PDGF mediates downstream signal transduction by binding to its receptor in its active form,playing an important role in the proliferation of fibroblasts and angiogenesis during the inflammation stage of myocardial fibrosis.Currently,although various PDGF receptor-targeted drugs have shown improvement in myocardial fibrosis in animal experiments,their effectiveness still needs to be validated through extensive clinical trials.

关键词

心肌纤维化/心肌梗死/血小板衍生生长因子

Key words

Myocardial fibrosis/Myocardial infarction/Platelet-derived growth factor

引用本文复制引用

基金项目

河北省2024年政府资助临床医学优秀人才培养项目(ZF2024023)

出版年

2024
中国心血管杂志
卫生部北京医院,天津医科大学

中国心血管杂志

CSTPCDCSCD北大核心
影响因子:0.993
ISSN:1007-5410
参考文献量5
段落导航相关论文